+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Benchtop NGS Sequencers Market - Global Forecast 2026-2032- Product Image
Benchtop NGS Sequencers Market - Global Forecast 2026-2032- Product Image
Sale

Benchtop NGS Sequencers Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6150403
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Benchtop NGS Sequencers Market is projected to reach USD 1.72 Billion in 2026. It is expected to continue growing at a CAGR of 9.18%, reaching USD 2.92 Billion by 2032.

Benchtop NGS Sequencers: Executive Overview

Benchtop next-generation sequencing (NGS) sequencers are compact systems designed to bring DNA and RNA sequencing closer to routine laboratory workflows. Their adoption is shaped by growing demand for faster turnaround, decentralized testing, targeted panels, clinical research, microbial analysis, oncology applications, and educational or core-facility use. The market is influenced by instrument usability, workflow automation, sample-to-answer integration, assay availability, data interpretation, regulatory requirements, and laboratory infrastructure.

Workflow Decentralization and Multipurpose Sequencing Reshape Adoption

Sequencing is increasingly moving beyond centralized facilities as laboratories seek practical systems that reduce transport requirements and support shorter decision cycles. Benchtop platforms benefit from compact footprints, flexible run configurations, simplified library preparation, and compatibility with targeted or small-panel workflows. Adoption also depends on reproducibility, quality control, maintenance requirements, consumables logistics, interoperability with laboratory information systems, and the availability of trained personnel. Demand is therefore shifting from instrument performance alone toward complete, reliable workflows that fit existing laboratory operations.

Artificial Intelligence Improves Interpretation, Automation, and Quality Control

Artificial intelligence is contributing to the benchtop NGS workflow through base-calling refinement, run-quality monitoring, variant prioritization, anomaly detection, sample tracking, and automated interpretation. Machine-learning tools can help laboratories manage complex datasets and identify clinically or scientifically relevant patterns, but their value depends on validated algorithms, representative training data, transparent performance measures, and appropriate human oversight. Data governance, cybersecurity, explainability, and regulatory alignment remain essential, particularly when sequencing results inform clinical decisions. AI is therefore best viewed as an enabling layer across the workflow rather than a substitute for laboratory validation or expert review.

Regional Insights: Infrastructure and Regulation Define Deployment Priorities

North America benefits from established research networks, advanced laboratory infrastructure, and active clinical and translational sequencing programs. Europe combines strong genomics capabilities with detailed regulatory and data-protection requirements, creating demand for validated and interoperable workflows. Asia-Pacific is supported by expanding healthcare capacity, research investment, and growing interest in localized testing, although access and reimbursement vary considerably. Latin America presents opportunities linked to infectious-disease surveillance, oncology, and academic research, while procurement constraints and uneven infrastructure can slow deployment. The Middle East is investing in precision-health and genomics initiatives, with adoption influenced by centralized programs and specialist capacity. Africa has important needs in infectious-disease monitoring, public-health research, and population genomics, but instrument access, logistics, training, and sustainable funding remain central considerations.

Group Insights: Policy Blocs and Economic Alliances Shape Access

ASEAN markets show varied readiness, with adoption influenced by laboratory modernization, cross-border research, procurement capability, and workforce development. BRICS countries reflect diverse healthcare systems and research priorities, including infectious-disease surveillance, agricultural genomics, and clinical applications. The European Union emphasizes harmonized regulation, cross-border data considerations, quality systems, and research collaboration. G7 countries generally have mature sequencing ecosystems and strong expectations for validation, cybersecurity, and clinical utility. GCC markets are developing genomics and precision-health programs, often emphasizing centralized infrastructure, specialist training, and national data strategies. NATO countries differ in healthcare structures but collectively place importance on resilient supply chains, biosurveillance, interoperability, and continuity of laboratory operations.

Country Insights: National Research Capacity and Use Cases Vary Widely

Australia supports sequencing through strong academic, public-health, agricultural, and clinical research networks. Brazil and Mexico are expanding applications in infectious disease, oncology, and public-health surveillance while facing regional differences in infrastructure and access. Canada combines public research capacity with geographically distributed healthcare needs. China is advancing genomics research, clinical laboratory capability, and domestic scientific infrastructure. India has substantial demand across diagnostics, epidemiology, and research, with affordability and workforce capacity remaining important. Japan and South Korea emphasize technologically advanced laboratories, automation, and precision medicine. France, Germany, Italy, Spain, and the United Kingdom have established research and healthcare ecosystems, with adoption shaped by evidence requirements, reimbursement, data governance, and laboratory accreditation. Russia’s sequencing activity is influenced by domestic research priorities, public-health applications, procurement conditions, and access to international supply chains. The United States has broad use across clinical research, public health, biotechnology, and academic laboratories, with validation, reimbursement, and regulatory compliance remaining central.

Priorities for Leaders: Build Validated, Interoperable, and Resilient Workflows

Industry leaders should evaluate benchtop NGS systems as complete workflows rather than standalone instruments. Priorities include simplifying library preparation, strengthening quality-control procedures, supporting open data and laboratory-system interoperability, and providing clear validation documentation. Organizations should align applications with defined clinical, research, or surveillance needs; invest in training and service capability; and establish contingency plans for consumables, maintenance, cybersecurity, and data storage. AI-enabled features should be adopted through documented validation, human review, bias assessment, and ongoing performance monitoring. Regional strategies should account for regulatory requirements, reimbursement conditions, infrastructure maturity, and local workforce availability.

Research Methodology: Evidence-Based Assessment of Technology and Adoption Drivers

This executive summary uses the supplied market category-benchtop NGS sequencers-as the analytical scope. The assessment is structured around documented technology characteristics, laboratory workflow requirements, sequencing applications, infrastructure conditions, regulatory considerations, public-health priorities, and regional or national implementation factors. Insights are synthesized qualitatively across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, and across the specified economic and policy groups and countries. No market estimates, market shares, forecasts, or company-specific claims are used. Findings should be validated against current regulatory guidance, procurement records, peer-reviewed research, laboratory performance data, and locally applicable reimbursement and accreditation rules before strategic decisions are made.

Conclusion: Practical Integration Will Determine Benchtop Sequencing Progress

Benchtop NGS sequencers are positioned to support more distributed, flexible, and application-specific sequencing workflows. Their practical impact will depend on dependable performance, accessible training, robust informatics, validated interpretation, and integration with laboratory systems rather than on instrument compactness alone. Regional and national differences in infrastructure, regulation, funding, and clinical adoption will produce varied implementation paths. Leaders that combine workflow design, evidence generation, responsible AI governance, and supply-chain resilience will be better prepared to translate benchtop sequencing capabilities into repeatable laboratory value.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Benchtop NGS Sequencers Market, by Technology
7.1. Introduction
7.2. Optical Sequencing
7.3. Semiconductor Sequencing
8. Benchtop NGS Sequencers Market, by Species
8.1. Introduction
8.2. Animal
8.3. Human
8.4. Microbial
8.5. Plant
9. Benchtop NGS Sequencers Market, by Application
9.1. Introduction
9.2. Genotyping
9.3. Metagenomics
9.4. Rna Sequencing
9.5. Targeted Resequencing
9.5.1. Amplicon Sequencing
9.5.2. Hybridization Capture
9.6. Whole Genome Sequencing
10. Benchtop NGS Sequencers Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals & Diagnostic Laboratories
10.5. Pharma & Biotech Companies
10.5.1. Biotech Companies
10.5.2. Pharma Companies
11. Benchtop NGS Sequencers Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Benchtop NGS Sequencers Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Benchtop NGS Sequencers Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Agilent Technologies, Inc.
15.2. Becton, Dickinson and Company
15.3. Danaher Corporation
15.4. F. Hoffmann-La Roche Ltd
15.5. llumina, Inc.
15.6. MGI Tech Co., Ltd.
15.7. Oxford Nanopore Technologies plc
15.8. Pacific Biosciences of California, Inc.
15.9. PerkinElmer, Inc.
15.10. Qiagen N.V.
15.11. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Benchtop NGS Sequencers Market, Years Considered for the Study
FIGURE 2. Global Benchtop NGS Sequencers Market, Research Design
FIGURE 3. Global Benchtop NGS Sequencers Market, Research Framework
FIGURE 4. Global Benchtop NGS Sequencers Market, Data Triangulation
FIGURE 5. Global Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Benchtop NGS Sequencers Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Benchtop NGS Sequencers Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Benchtop NGS Sequencers Market Size, by Species, 2025 vs 2032 (%)
FIGURE 9. Global Benchtop NGS Sequencers Market Size, by Species, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Benchtop NGS Sequencers Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Benchtop NGS Sequencers Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Benchtop NGS Sequencers Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Benchtop NGS Sequencers Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Benchtop NGS Sequencers Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Benchtop NGS Sequencers Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Benchtop NGS Sequencers Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Benchtop NGS Sequencers Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Benchtop NGS Sequencers Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Benchtop NGS Sequencers Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Benchtop NGS Sequencers Market Segmentation & Coverage
TABLE 2. Global Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 3. Global Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Optical Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Optical Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Optical Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Semiconductor Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Semiconductor Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Semiconductor Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 11. Global Animal Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Animal Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Animal Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Human Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Human Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Human Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Microbial Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Microbial Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Microbial Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Plant Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Plant Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Plant Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Genotyping Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Genotyping Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Genotyping Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Metagenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Metagenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Metagenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Rna Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Rna Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Rna Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Targeted Resequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Targeted Resequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Targeted Resequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Amplicon Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Amplicon Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Amplicon Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Hybridization Capture Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Hybridization Capture Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Hybridization Capture Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 46. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Hospitals & Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Hospitals & Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Hospitals & Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pharma & Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Pharma & Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Pharma & Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Pharma Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Pharma Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Pharma Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Benchtop NGS Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Benchtop NGS Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 72. North America Benchtop NGS Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. North America Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 74. North America Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 75. North America Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. North America Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 77. North America Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. North America Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 79. Latin America Benchtop NGS Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Latin America Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 81. Latin America Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 82. Latin America Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Latin America Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 84. Latin America Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Latin America Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 86. Europe Benchtop NGS Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Europe Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 88. Europe Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 89. Europe Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. Europe Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 91. Europe Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Europe Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 93. Middle East Benchtop NGS Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Middle East Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 95. Middle East Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 96. Middle East Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Middle East Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 98. Middle East Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Middle East Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 100. Africa Benchtop NGS Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Africa Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Africa Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 103. Africa Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Africa Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 105. Africa Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Africa Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 107. Global Benchtop NGS Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. ASEAN Benchtop NGS Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. ASEAN Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 111. ASEAN Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. ASEAN Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 113. ASEAN Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. ASEAN Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 115. GCC Benchtop NGS Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. GCC Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 117. GCC Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 118. GCC Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. GCC Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 120. GCC Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. GCC Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 122. European Union Benchtop NGS Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. European Union Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. European Union Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 125. European Union Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. European Union Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 127. European Union Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. European Union Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 129. BRICS Benchtop NGS Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. BRICS Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 131. BRICS Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 132. BRICS Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. BRICS Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 134. BRICS Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. BRICS Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 136. G7 Benchtop NGS Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. G7 Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. G7 Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 139. G7 Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. G7 Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 141. G7 Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. G7 Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 143. NATO Benchtop NGS Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. NATO Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. NATO Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 146. NATO Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. NATO Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 148. NATO Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. NATO Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 150. Global Benchtop NGS Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. United States Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 152. United States Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. United States Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 154. United States Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. United States Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 156. United States Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. United States Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 158. Canada Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 159. Canada Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. Canada Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 161. Canada Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Canada Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 163. Canada Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Canada Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 165. Mexico Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 166. Mexico Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. Mexico Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 168. Mexico Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Mexico Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 170. Mexico Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Mexico Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 172. Brazil Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 173. Brazil Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 174. Brazil Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 175. Brazil Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Brazil Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 177. Brazil Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Brazil Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 179. United Kingdom Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 180. United Kingdom Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. United Kingdom Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 182. United Kingdom Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. United Kingdom Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 184. United Kingdom Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. United Kingdom Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 186. Germany Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 187. Germany Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. Germany Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 189. Germany Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Germany Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 191. Germany Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Germany Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 193. France Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 194. France Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. France Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 196. France Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. France Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 198. France Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. France Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 200. Russia Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 201. Russia Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. Russia Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 203. Russia Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Russia Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 205. Russia Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Russia Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 207. Italy Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 208. Italy Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. Italy Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 210. Italy Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Italy Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 212. Italy Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Italy Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 214. Spain Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 215. Spain Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. Spain Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 217. Spain Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Spain Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 219. Spain Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Spain Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 221. China Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 222. China Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 223. China Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 224. China Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. China Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 226. China Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. China Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 228. India Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 229. India Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 230. India Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 231. India Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. India Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 233. India Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. India Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 235. Japan Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 236. Japan Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. Japan Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 238. Japan Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Japan Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 240. Japan Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Japan Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 242. Australia Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 243. Australia Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 244. Australia Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 245. Australia Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. Australia Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 247. Australia Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Australia Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 249. South Korea Benchtop NGS Sequencers Market Size, 2017-2032 (USD Million)
TABLE 250. South Korea Benchtop NGS Sequencers Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. South Korea Benchtop NGS Sequencers Market Size, by Species, 2017-2032 (USD Million)
TABLE 252. South Korea Benchtop NGS Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. South Korea Benchtop NGS Sequencers Market Size, by Targeted Resequencing, 2017-2032 (USD Million)
TABLE 254. South Korea Benchtop NGS Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. South Korea Benchtop NGS Sequencers Market Size, by Pharma & Biotech Companies, 2017-2032 (USD Million)
TABLE 256. Global Benchtop NGS Sequencers Market Share, by Key Player, 2025
TABLE 257. Global Benchtop NGS Sequencers Market, Key Experts

Companies Mentioned

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • llumina, Inc.
  • MGI Tech Co., Ltd.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report 2026 - Product Image

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Next-Generation Sequencing (NGS) in Precision Medicine Market Report 2026 - Product Image

Next-Generation Sequencing (NGS) in Precision Medicine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
NGS-Based RNA-Sequencing Market - Global Forecast 2026-2032 - Product Image

NGS-Based RNA-Sequencing Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
NGS Library Preparation Market - Global Forecast 2026-2032 - Product Image

NGS Library Preparation Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
NGS Kits Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Nucleotide Sequenced, Type of End User and Key Geographical Regions - Product Image

NGS Kits Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Nucleotide Sequenced, Type of End User and Key Geographical Regions

  • Report
  • 218 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.